Intensity Dependence of Auditory-Evoked Cortical Potentials in Fibromyalgia Patients: A Test of the Generalized Hypervigilance Hypothesis

Journal of Pain

Volumn 7, Issue 7, 2006, Pages 480-487

  Carrillo de la Pena M T ^a   Vallet, M ^b   Perez M I ^b   Gomez Perretta C ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

auditory evoked potentials (AEPs); Fibromyalgia; generalized hypervigilance; high intensity stimulation; inhibitory mechanisms; serotonergic deficit

Indexed keywords

ADULT; ALERTNESS; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; FIBROMYALGIA; HUMAN; LATENT PERIOD; PATHOPHYSIOLOGY; SEROTONINERGIC SYSTEM; SOUND INTENSITY;

ACOUSTIC STIMULATION; ADULT; AFFERENT PATHWAYS; AGE FACTORS; AGED; AROUSAL; AUDITORY PATHWAYS; AUDITORY PERCEPTION; AUDITORY THRESHOLD; CEREBRAL CORTEX; EDUCATIONAL STATUS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; FIBROMYALGIA; HUMANS; MARITAL STATUS; MIDDLE AGED; NEURAL INHIBITION; PAIN; PAIN THRESHOLD; REACTION TIME; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 33745265262     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2006.01.452     Document Type: Article

References (64)

1. Ambrosini A., and Schoenen J. The electrophysiology of migraine. Curr Opin Neurol 16 (2003) 327-331
2. Ambrosini A., Rossi P., De Pasqua V., Pierelli F., and Schoenen J. Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 126 (2003) 2009-2015
3. Arnold L.M., Hess E.V., Hudson J.I., Berno S.E., and Keck P.E.A. Randomized, placebo-controlled, double blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112 (2002) 191-197
4. Bhalang K., Sigurdsson A., Slade G.D., and Maixner W. Associations among four modalities of experimental pain in women. J Pain 6 (2005) 604-611
5. Berglund B., Harju E.L., Kosek E., and Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 96 (2002) 177-187
6. Bruneau N., Barthélémy C., Roux S., Jouve J., and Lelord G. Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior. Neuropsychobiology 21 (1989) 48-52
7. Chapman C.R. Pain, perception, and illusion. In: Sternbach R.A. (Ed). The Psychology of Pain (1986), Raven Press, New York, NY 153-179
8. Chitour D., Dickenson A.H., and Le Bars D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Res 236 (1982) 329-337
9. Crombez G., Eccleston C., Van den Broeck A., Goubert L., and Van Houdenhove B. Hypervigilance to pain in fibromyalgia. The mediating role of pain intensity and catastrophic thinking about pain. Clin J Pain 20 (2004) 98-102
10. Desmeules J.A., Cedraschi C., Rapiti E., Baumgartner E., Finckh A., Cohen P., Dayer P., and Vischer T.L. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48 (2003) 1420-1429
11. Dohrenbusch R. Sind Fibromyalgiepatienten "hypervigilant"?. [Are patients with fibromyalgia "hypervigilant"?]. Schmerz 15 (2001) 38-47
12. Dohrenbusch R., Sodhi H., Lamprecht J., and Genth E. Fibromyalgia as a disorder of perceptual organization? An analysis of acoustic stimulus processing in patients with widespread pain. Z Rheumatol 56 (1997) 334-341
13. Fischer A.A. Pressure algometry over normal muscles. standard values, validity and reproducibility of pressure threshold. Pain 30 (1987) 115-126
14. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuβ H.J., Mavrogiourgou P., Munke A., and Hegerl U. The loudness dependence of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148 (2000) 404-411
15. Ge H.Y., Madeleine P., and Arendt-Nielsen L. Sex differences in temporal characteristics of descending inhibitory control. An evaluation using repeated bilateral experimental induction of muscle pain. Pain 110 (2004) 72-78
16. Geisser M.E., Casey K.L., Brucksch C.B., Ribbens C.M., Appleton B.B., and Crofford L.J. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia. Association with mood, somatic focus, and catastrophizing. Pain 102 (2003) 243-250
17. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58 (1994) 185-193
18. Giffin N.J., and Kaube H. The electrophysiology of migraine. Curr Opin Neurol 15 (2002) 303-309
19. Gracely R.H., Grant M.A., and Giesecke T. Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17 (2003) 593-609
20. Hegerl U., Gallinat J., and Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 62 (2001) 93-100
21. Hegerl U., and Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission. A new hypothesis. Biol Psychiatry 33 (1993) 173-187
22. Hurtig I.M., Raak R.I., Kendall S.A., Gerdle B., and Wahren L.K. Quantitative sensory testing in fibromyalgia patients and in healthy subjects. Identification of subgroups. Clin J Pain 17 (2001) 316-322
23. Juckel G., Hegerl U., Molnár M., Csépe V., and Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity-A study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21 (1999) 710-716
24. Juckel G., Molnár M., Hegerl U., Csepe V., and Karmos G. Auditory evoked potentials as indicator of brain serotonergic activity-First evidence in behaving cats. Biol Psychiatry 41 (1997) 1181-1195
25. Juhl J.H. Fibromyalgia and the serotonin pathway. Altern Med Rev 3 (1998) 367-375
26. Kosek E., Ekholm J., and Hansson P. Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68 (1996) 375-383
27. Kosek E., and Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70 (1997) 41-51
28. Lautenbacher S., Rollman G.B., and McCain G.A. Multimethod assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59 (1994) 45-53
29. Lautenbacher S., and Rollman G.B. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13 (1997) 189-196
30. Lorenz J., Grasedyck K., and Bromm B. Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 100 (1996) 165-168
31. Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 57 (1998) 19-22
32. Maquet D., Croisier J.L., Demoulin C., and Crielaard J.M. Pressure pain thresholds of tender points in patients with fibromyalgia and in healthy controls. Eur J Pain 8 (2004) 111-117
33. McDermid A.J., Rollman G.B., and McCain G.A. Generalized hypervigilance in fibromyalgia. Evidence of perceptual amplification. Pain 66 (1996) 133-144
34. Miller L.J., and Kubes K.L. Serotonergic agents in the treatment of fibromyalgia syndrome. Ann Pharmacother 36 (2002) 707-712
35. Montoya P., Pauli P., Batra A., and Wiedemann G. Altered processing of pain-related information in patients with fibromyalgia. Eur J Pain 9 (2005) 293-303
36. Mountz J.M., Bradley L.A., Modell J.G., Alexander R.W., Triana-Alexander M., Aaron L.A., Stewart K.E., Alarcón G.S., and Mountz J.D. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38 (1995) 926-938
37. Ozgocmen S., Yoldas T., Kamanli A., Yildizhan H., Yigiter R., and Ardicoglu O. Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia. Ann Rheum Dis 62 (2003) 551-555
38. Paige S.R., Fitzpatrick D.F., Kline J.P., Balogh S., and Hendricks S.E. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 30 (1994) 197-201
39. Patkar A.A., Bilal L., and Masand P.S. Management of fibromyalgia. Curr Psychiatry Rep 5 (2003) 218-224
40. Peters M.L., Vlaeyen J.W., and van Drunen C. Do fibromyalgia patients display hypervigilance for innocuous somatosensory stimuli? Application of a body scanning reaction time paradigm. Pain 86 (2000) 283-292
41. Petrie A. Some psychological aspects of pain and the relief of suffering. Ann N Y Acad Sci 86 (1960) 13-27
42. Petrie A. Individuality in Pain and Suffering (1967), University of Chicago Press, Chicago, IL
43. Petrie A. Individuality in Pain and Suffering. 2nd ed. (1978), University of Chicago Press, Chicago, IL
44. Petzke F., Clauw D.J., Ambrose K., Khine A., and Gracely R.H. Increased pain sensitivity in fibromyalgia. Effects of stimulus type and mode of presentation. Pain 105 (2003) 403-413
45. Price D.D., Staud R., Robinson M.E., Mauderli A.P., Cannon R., and Vierck C.J. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99 (2002) 49-59
46. Proietti-Cecchini A., Afra J., and Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man. Demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 17 (1997) 849-854
47. Riering K., Rewerts C., and Zieglgänsberger W. Analgesic effects of 5-HT3 receptor antagonists. Scand J Rheumatol Suppl 119 (2004) 19-23
48. Rollman G.B. Measurement of pain in fibromyalgia in the clinic and laboratory. J Rheumatol Suppl 19 (1989) 113-119
49. Sarkar S., Hobson A.R., Furlong P.L., Woolf C.J., Thompson D.G., and Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 281 (2001) G1196-G1202
50. Schwarz M.J., Offenbaecher M., Neumeister A., Ewert T., Willeit M., Praschak-Rieder N., Zach J., Zacherl M., Lossau K., Weisser R., Stucki G., and Ackenheil M. Evidence for an altered tryptophan metabolism in fibromyalgia. Neurobiol Dis 11 (2002) 434-442
51. Schwarz M.J., Späth M., Müller-Bardorff H., Pongratz D.E., Bondy B., and Ackenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 259 (1999) 196-198
52. Schwerdtfeger A., Getzmann S., and Baltissen R. Fast reducers, slow augmenters. A psychophysiological analysis of temperament-related differences in reaction time. Int J Psychophysiol 52 (2004) 225-237
53. Siniatchkin M., Kropp P., Neumann M., Gerber W., and Stephani U. Intensity dependence of auditory evoked cortical potentials in migraine families. Pain 85 (2000) 247-254
54. Staud R. Evidence of involvement of central neural mechanisms in generation of fibromyalgia pain. Curr Rheumatol Rep 4 (2002) 299-305
55. Staud R. New evidence for central sensitization in patients with fibromyalgia. Curr Rheumatol Rep 6 (2004) 259
56. Staud R., Robinson M.E., Vierck Jr. C.J., and Price D.D. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 101 (2003) 167-174
57. Vasey M.W., and Thayer J.F. The continuing problem of false positives in repeated measures ANOVA in psychophysiology. A multivariate solution. Psychophysiology 24 (1987) 479-486
58. Villanueva L., Chitour D., and Le Bars D. Involvement of the dorsolateral funiculus in the descending spinal projections responsible for diffuse noxious inhibitory controls in the rat. J Neurophysiol 56 (1986) 1185-1195
59. von Knörring L., Almay B.G., Johansson F., and Terenius L. Endorphins in CSF of chronic pain patients, in relation to augmenting-reducing response in visual averaged evoked response. Neuropsychobiology 5 (1979) 322-326
60. von Knörring L. The experience of pain in depressed patients. A clinical and experimental study. Neuropsychobiology 1 (1975) 155-165
61. Wang W., Timsit-Berthier M., and Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine. An indication of cortical potentiation and low serotonergic neurotransmission?. Neurology 46 (1996) 1404-1409
62. Wang W., Wang Y.H., Fu X.M., Sun Z.M., and Schoenen J. Auditory evoked potentials and multiple personality measures in migraine and post-traumatic headaches. Pain 79 (1999) 235-242
63. Wolfe F., Russell I.J., Vipraio G., Ross K., and Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 24 (1997) 555-559
64. Wolfe F., Smythe H.A., Yunus M.B., Bennet R.M., Bombardier C., Goldenb D.L., Tugwell P., Campbell S.M., Abeles M., and Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172